{"disease":{"id":"achondroplasia","name":"achondroplasia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01516229","title":"Special Survey for Long Term Application","phase":"","overall_status":"COMPLETED","enrollment_count":395,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT03794609","title":"Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia.","phase":"","overall_status":"TERMINATED","enrollment_count":315,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT05145010","title":"Extension Study of Infigratinib in Children With Achondroplasia (ACH)","phase":"PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":300,"lead_sponsor_name":"QED Therapeutics, a BridgeBio company","has_results":false},{"nct_id":"NCT04035811","title":"Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)","phase":"","overall_status":"COMPLETED","enrollment_count":271,"lead_sponsor_name":"QED Therapeutics, a BridgeBio company","has_results":false},{"nct_id":"NCT07301463","title":"A Study in Children With Achondroplasia","phase":"","overall_status":"RECRUITING","enrollment_count":260,"lead_sponsor_name":"Abbisko Therapeutics Co, Ltd","has_results":false},{"nct_id":"NCT03875534","title":"A Multi-center, Longitudinal, Observational Study of Children With Achondroplasia","phase":"","overall_status":"COMPLETED","enrollment_count":260,"lead_sponsor_name":"Ascendis Pharma A/S","has_results":false},{"nct_id":"NCT05659719","title":"A Study to Learn About Recifercept in Patients With Achondroplasia","phase":"","overall_status":"COMPLETED","enrollment_count":248,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT05328050","title":"Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy)","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","has_results":false},{"nct_id":"NCT03449368","title":"Lifetime Impact of Achondroplasia Study in Europe-LIAISE","phase":"","overall_status":"COMPLETED","enrollment_count":196,"lead_sponsor_name":"BioMarin Pharmaceutical","has_results":false},{"nct_id":"NCT03872531","title":"Lifetime Impact Study for Achondroplasia","phase":"","overall_status":"COMPLETED","enrollment_count":173,"lead_sponsor_name":"BioMarin Pharmaceutical","has_results":false},{"nct_id":"NCT05603936","title":"Adaption and Testing of the Quality of Life in Short Stature Youth (QoLISSY) Questionnaire for Parents With Children From 0-4","phase":"","overall_status":"UNKNOWN","enrollment_count":168,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT03197766","title":"A Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":121,"lead_sponsor_name":"BioMarin Pharmaceutical","has_results":true},{"nct_id":"NCT06164951","title":"A Study to Evaluate the Efficacy and Safety of Infigratinib in Children and Adolescents With Achondroplasia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":114,"lead_sponsor_name":"QED Therapeutics, a BridgeBio company","has_results":false},{"nct_id":"NCT07297875","title":"A Study of ABSK061 to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy in Children With Achondroplasia","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":110,"lead_sponsor_name":"Abbisko Therapeutics Co, Ltd","has_results":false},{"nct_id":"NCT05598320","title":"A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Children With Achondroplasia","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":84,"lead_sponsor_name":"Ascendis Pharma Growth Disorders A/S","has_results":false},{"nct_id":"NCT04265651","title":"Study of Infigratinib in Children With Achondroplasia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":84,"lead_sponsor_name":"QED Therapeutics, a BridgeBio company","has_results":false},{"nct_id":"NCT01435629","title":"A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin","phase":"","overall_status":"COMPLETED","enrollment_count":81,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT03583697","title":"A Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With Achondroplasia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"BioMarin Pharmaceutical","has_results":true},{"nct_id":"NCT04638153","title":"A Study Of Safety, Tolerability And Effectiveness Of Recifercept In Children With Achondroplasia","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":60,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04085523","title":"A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of TransCon CNP Administered Once Weekly in Prepubertal Children With Achondroplasia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"Ascendis Pharma A/S","has_results":true},{"nct_id":"NCT03780153","title":"The Norwegian Adult Achondroplasia Study","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Sunnaas Rehabilitation Hospital","has_results":false},{"nct_id":"NCT05813314","title":"Bioequivalence Study to Compare Two Injection Devices for BMN 111 in Healthy Participants","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":36,"lead_sponsor_name":"BioMarin Pharmaceutical","has_results":false},{"nct_id":"NCT02055157","title":"A Phase 2 Study of BMN 111 to Evaluate Safety, Tolerability, and Efficacy in Children With Achondroplasia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"BioMarin Pharmaceutical","has_results":true},{"nct_id":"NCT05116046","title":"Continuation Study of Long-term Safety, Tolerability, Pharmacokinetics and Efficacy of Recifercept in Achondroplasia","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":35,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT06926491","title":"Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia（AOBA Study）","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":6,"lead_sponsor_name":"Kyowa Kirin Co., Ltd.","has_results":false},{"nct_id":"NCT03866200","title":"Resveratrol Trial for Relief of Pain in Pseudoachondroplasia","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"The University of Texas Health Science Center, Houston","has_results":true}],"total":26},"guidelines":[],"source":"Drug Landscape verified database"}